Skip to main content
Clinical Trials/NCT03533829
NCT03533829
Completed
Not Applicable

Preventing Post-Vaccination Presyncope and Syncope in Adolescents Using Simple, Clinic-based Interventions: A Pilot Study

Duke University2 sites in 1 country30 target enrollmentJune 4, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Syncope, Vasovagal
Sponsor
Duke University
Enrollment
30
Locations
2
Primary Endpoint
Number of Subjects Who Have Buzzy® Applied to and Kept at Vaccination Site/s for ≥ 30 Seconds Prior to Vaccination
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This is a randomized controlled open-label trial. During the study, adolescents scheduled to receive at least one intramuscular (IM) vaccine will receive either Buzzy®, Music, or Buzzy® and Music intervention(s) in addition to standard care to evaluate the feasibility and acceptability of these interventions prior to being used in a larger study to assess the effectiveness of the interventions in preventing post-vaccination presyncope and syncope. Feasibility will be assessed according to study staff ability to successfully administer the protocol specified clinic-based interventions and per both study staff and healthcare provider responses to written feasibility assessments. Acceptability will be assessed according to the participant's self-report. In addition, baseline needle phobia and anxiety, post-vaccination pain and presyncope symptoms, and pre- and post- vaccination state anxiety will be assessed per participant written self-report to standardized survey questions.

Registry
clinicaltrials.gov
Start Date
June 4, 2018
End Date
July 19, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 10 years through 17 years of age
  • If 10 through 13 years of age, the subject must be receiving at least one vaccine delivered intramuscularly
  • If 14 through 17 years of age, the subject must be receiving at least two injectable vaccines one of which must be delivered intramuscularly
  • The parent/guardian must be willing and capable of providing written informed consent for the adolescent and the adolescent must be willing and capable of providing assent.
  • The subject must be willing to stay for the completion of all study-related activities.
  • Parent/guardian and adolescent must speak and read English by self-report

Exclusion Criteria

  • Receipt of investigational or experimental vaccine or medication within the previous two weeks
  • Receipt of routine injectable medication
  • Permanent indwelling venous catheter
  • Blood drawn within the past hour or scheduled for a blood draw during the post-vaccination observation period
  • Injection of medication during the past hour or scheduled for injection of medication during the observation period.
  • Cold intolerance or cold urticaria
  • Raynaud's phenomenon
  • Sickle cell disease
  • Inability to hear
  • Significant visual impairment or blindness

Outcomes

Primary Outcomes

Number of Subjects Who Have Buzzy® Applied to and Kept at Vaccination Site/s for ≥ 30 Seconds Prior to Vaccination

Time Frame: Day1

Buzzy® will be applied to and kept on the subjects arm for a minimum of 30 seconds prior to vaccination.

Number of Subjects Who Have Music Playing for 10 Minutes Post Vaccination

Time Frame: Day1

Music will be played over speakers through the 10 minute post vaccination pain assessment

Number of Subjects Who Have Buzzy® Kept on Vaccination Arm/s During the Entire Vaccination Procedure

Time Frame: Day1

Buzzy® will be applied to and kept on the subjects arm for the duration of the vaccination procedure.

Number of Subjects Who Have Music Playing for ≥ 3 Minutes Prior to Vaccination

Time Frame: Day1

Music will be played over speakers for a minimum of 3 minutes prior to vaccination

Number of Subjects Who Complete the Post-vaccination Pain Assessment at 1 Minute.

Time Frame: Day1

Subjects will complete a post vaccination pain assessment within one minute of their final vaccination

Number of Subjects Who Complete the Post Vaccination Anxiety Assessment

Time Frame: Day1

Subjects will complete a post vaccination anxiety assessment

Number of Reports From Providers That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Easy or Very Easy

Time Frame: Day1

Providers will answer a questionnaire about the feasibility of the music intervention after each encounter with a subject

Number of Reports From Providers That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Assistive or Very Assistive

Time Frame: Day1

Providers will answer a questionnaire about the feasibility of the music intervention after each encounter with a subject

Number of Reports From Providers That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Easy or Very Easy

Time Frame: Day1

Providers will answer a questionnaire about the feasibility of the Buzzy® intervention after each encounter with a subject

Number of Subjects Who Found the Music App Sufficient or Somewhat Sufficient to Selecting the Music They Like

Time Frame: Day1

Subjects will complete a survey about the acceptability of the music intervention during their vaccinations

Number of Subjects Who Found Having Buzzy® on Their Arm/s During Shot/s Somewhat Easy or Very Easy

Time Frame: Day1

Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations

Number of Subjects Who Complete the Pre-vaccination Anxiety Assessment

Time Frame: Day1

Subjects will be asked to complete an anxiety assessment prior to vaccination

Number of Subjects Who Complete the Pre-vaccination Needle Phobia Assessment

Time Frame: Day1

Subjects will be asked to complete a needle phobia assessment pre-vaccination

Number of Subjects Who Complete the Post-vaccination Pain Assessment at 10 Minutes

Time Frame: Day1

Subjects will complete a post vaccination pain assessment at 10 minutes after their final vaccination

Number of Subjects Who Complete the Post-vaccination Presyncope Symptom Assessment

Time Frame: Day1

Subjects will complete a questionnaire about presyncope symptoms after their vaccination/s

Number of Subjects Who Complete the Acceptability Assessment

Time Frame: Day1

Subjects will be given a questionnaire about the acceptability of their intervention.

Number of Reports From Coordinators That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Easy or Very Easy

Time Frame: Day1

Coordinators will answer a questionnaire about the feasibility of the music intervention after each encounter with a subject

Number of Reports From Coordinators That Indicated Having Music Playing During the Vaccine Administration Was Somewhat Assistive or Very Assistive

Time Frame: Day1

Coordinators will answer a questionnaire about the feasibility of the music intervention after each encounter with a subject

Number of Reports From Coordinators That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Easy or Very Easy

Time Frame: Day1

Coordinators will answer a questionnaire about the feasibility of the Buzzy® intervention after each encounter with a subject

Number of Reports From Coordinators That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Assistive or Very Assistive

Time Frame: Day1

Coordinators will answer a questionnaire about the feasibility of the Buzzy® intervention after each encounter with a subject

Number of Subjects Who Found Having Buzzy® on Their Arm/s During Shot/s Somewhat Comfortable or Very Comfortable

Time Frame: Day1

Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations

Number of Subjects Who Were Not Bothered by the Cold Temperature of Buzzy® on Their Arm/s During Shot/s

Time Frame: Day1

Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations

Number of Subjects Who Found the Music Playing While They Got Their Shot/s to be Just Right

Time Frame: Day1

Subjects will complete a survey about the acceptability of the music intervention during their vaccinations

Number of Subjects Who Would be Somewhat Likely or Very Likely to Want to Listen to Music Again While Receiving Shot/s

Time Frame: Day1

Subjects will complete a survey about the acceptability of the music intervention during their vaccinations

Number of Subjects Who Were Not Bothered by the Vibration of Buzzy® on Their Arm/s During Shot/s

Time Frame: Day1

Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations

Number of Subjects Who Would Choose to Have Buzzy® on Their Arm/s During Shot/s Again

Time Frame: Day1

Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations

Number of Subjects Who Either Like a Little or Very Much Liked Having Buzzy® on Their Arm/s During Shot/s

Time Frame: Day1

Subjects will complete a survey about the acceptability of the Buzzy® intervention during their vaccinations

Number of Reports From Providers That Indicated Having Buzzy® Applied in Conjunction With the Vaccination Was Somewhat Assistive or Very Assistive

Time Frame: Day1

Providers will answer a questionnaire about the feasibility of the Buzzy® intervention after each encounter with a subject

Number of Subjects Who Like Having Music Play During Their Shot/s a Little or Very Much

Time Frame: Day1

Subjects will complete a survey about the acceptability of the music intervention during their vaccinations

Number of Subjects Who Felt Having Music Play During Their Shot/s Was Somewhat Easy or Easy

Time Frame: Day1

Subjects will complete a survey about the acceptability of the music intervention during their vaccinations

Number of Subjects Who Found Music Playing While Receiving Their Shots to be Somewhat Comfortable or Very Comfortable

Time Frame: Day1

Subjects will complete a survey about the acceptability of the music intervention during their vaccinations

Study Sites (2)

Loading locations...

Similar Trials